Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: AVR

Anteris Technologies Global Corp.

Healthcare | Medical - Devices

No licensed closing price on file for AVR. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Anteris Technologies Global Corp. (NASDAQ: AVR) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 01:49 UTC.

What Anteris Technologies Global Corp. does

Anteris is a structural heart company developing the DurAVR THV System to treat aortic stenosis, a serious narrowing of the aortic valve that can be fatal if left untreated. The DurAVR THV is a single-piece, biomimetic valve designed to mimic a healthy human aortic valve and uses proprietary ADAPT tissue-enhancing technology to reduce calcium buildup. The system includes a balloon-expandable delivery mechanism developed with physician input for precise valve placement.

Summarized from Anteris Technologies Global Corp.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity101,230.11%

Revenue, margins & earnings

FY2024: net loss $76M on revenue $3M$3MFY2024FY2025: net loss $94M on revenue $2M$2MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-08
  • 2026-10-0810% OwnerPurchase272,695$1.96M
  • 2026-10-0610% OwnerPurchase648,455$4.87M
  • 2026-10-0610% OwnerPurchase236,354$1.84M
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →
No qualifying company news in the archive. Full tape in the platform →

Questions this page answers

What does Anteris Technologies Global Corp. do?

Anteris is a structural heart company developing the DurAVR THV System to treat aortic stenosis, a serious narrowing of the aortic valve that can be fatal if left untreated.

When did AVR last file with the SEC?

Anteris Technologies Global Corp.'s most recent SEC filing on record is a 8-K filed 2026-05-22. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 01:49 UTC. This page is also available as JSON at /api/data?ticker=AVR and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for AVR and 5,000+ tickers.

Create a free account — keep AVR
For your agent
GET /api/data?ticker=AVR

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt